NZ215717A - Cephalosporin derivatives - Google Patents

Cephalosporin derivatives

Info

Publication number
NZ215717A
NZ215717A NZ215717A NZ21571786A NZ215717A NZ 215717 A NZ215717 A NZ 215717A NZ 215717 A NZ215717 A NZ 215717A NZ 21571786 A NZ21571786 A NZ 21571786A NZ 215717 A NZ215717 A NZ 215717A
Authority
NZ
New Zealand
Prior art keywords
cephalosporin derivatives
cephalosporin
derivatives
Prior art date
Application number
NZ215717A
Other languages
English (en)
Inventor
Hoshi Hideaki
Okumura Jun
Abe Yoshio
Naito Takayuki
Aburaki Shimpei
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of NZ215717A publication Critical patent/NZ215717A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/187-Aminocephalosporanic or substituted 7-aminocephalosporanic acids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/227-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with radicals containing only hydrogen and carbon atoms, attached in position 3
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Cephalosporin Compounds (AREA)
NZ215717A 1985-04-22 1986-04-07 Cephalosporin derivatives NZ215717A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US72587185A 1985-04-22 1985-04-22

Publications (1)

Publication Number Publication Date
NZ215717A true NZ215717A (en) 1989-06-28

Family

ID=24916301

Family Applications (1)

Application Number Title Priority Date Filing Date
NZ215717A NZ215717A (en) 1985-04-22 1986-04-07 Cephalosporin derivatives

Country Status (38)

Country Link
JP (1) JPS61249989A (fr)
KR (1) KR860008189A (fr)
CN (1) CN1015714B (fr)
AR (1) AR242581A1 (fr)
AT (1) AT392072B (fr)
AU (1) AU589170B2 (fr)
BE (1) BE904646A (fr)
CA (1) CA1273629A (fr)
CH (1) CH671399A5 (fr)
CS (1) CS270435B2 (fr)
CY (1) CY1571A (fr)
DD (1) DD244557A5 (fr)
DE (1) DE3613365A1 (fr)
DK (1) DK163584C (fr)
EG (1) EG18001A (fr)
ES (1) ES8800236A1 (fr)
FI (1) FI84268C (fr)
FR (1) FR2580652B1 (fr)
GB (1) GB2173798B (fr)
GR (1) GR861065B (fr)
HK (1) HK106290A (fr)
HU (1) HU195223B (fr)
IE (1) IE59014B1 (fr)
IT (1) IT1228241B (fr)
LU (1) LU86402A1 (fr)
MY (1) MY100694A (fr)
NL (1) NL192205C (fr)
NO (1) NO164659C (fr)
NZ (1) NZ215717A (fr)
OA (1) OA08245A (fr)
PT (1) PT82436B (fr)
SE (1) SE500217C2 (fr)
SG (1) SG90890G (fr)
SU (1) SU1435155A3 (fr)
YU (1) YU43697B (fr)
ZA (1) ZA862985B (fr)
ZM (1) ZM4286A1 (fr)
ZW (1) ZW9086A1 (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
US4870168A (en) * 1987-02-26 1989-09-26 Bristol-Myers Company 3-Unsaturated alkyl cephems from 3-triflyl cephems
DE3933934A1 (de) * 1989-10-03 1991-04-11 Bayer Ag Verfahren zur herstellung von 7-amino-3-((z)-1-propen-1-yl)-3-cephem-4-carbonsaeure
DE69231815T2 (de) * 1991-03-08 2001-09-27 Biochemie Ges.M.B.H., Kundl Verfahren zur Herstellung von Cephalosporinen und Zwischenprodukte in diesem Verfahren
AT399876B (de) * 1992-02-05 1995-08-25 Biochemie Gmbh Verfahren zur abreicherung von 7-amino-3-((e)-1- propen-1-yl)-3-cephem-4-carbonsäure
JP2825655B2 (ja) * 1992-02-05 1998-11-18 バイオケミ・ゲゼルシヤフト・エム・ベー・ハー 3−セフェム−4−カルボン酸誘導体の精製方法
JPH07173168A (ja) * 1993-07-14 1995-07-11 Sumitomo Chem Co Ltd セフェム系化合物、その製法、およびそれのセフェム系抗生物質製造への利用
WO2004033464A1 (fr) * 2002-10-08 2004-04-22 Ranbaxy Laboratories Limited Procede de preparation d'acide 7-amino-3-propene-1-yl-3-cephem-4 carboxylique enrichi en isomere (z)
US7544797B2 (en) 2003-10-30 2009-06-09 Cj Cheiljedang Corporation Processes for the preparation of cephem derivatives
JP4046708B2 (ja) * 2004-06-04 2008-02-13 明治製菓株式会社 3−アルケニルセフェム化合物の製造方法
EP1809638B1 (fr) 2004-11-01 2010-02-17 Hetero Drugs Limited Nouveau procede de preparation d"un intermediaire du cefprozil
CN103183686B (zh) * 2011-12-30 2016-06-29 浙江新和成股份有限公司 7β-氨基-7α-甲氧基-3-头孢烯化合物的制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110534A (en) * 1970-01-23 1978-08-29 Glaxo Laboratories Limited Process for the preparation of 3-vinyl and substituted vinyl cephalosporins
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US3769277A (en) * 1970-01-23 1973-10-30 Glaxo Lab Ltd Preparation of delta3-4 carboxy cephalosporins having a 3-vinyl or substituted 3-vinyl group
US4065620A (en) * 1971-06-14 1977-12-27 Eli Lilly And Company 3-(Substituted) vinyl cephalosporins
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
US4520022A (en) * 1983-01-28 1985-05-28 Bristol-Myers Company Substituted vinyl cephalosporins
AU566944B2 (en) * 1983-10-07 1987-11-05 Gist-Brocades N.V. Preparation of 3-cephem derivatives

Also Published As

Publication number Publication date
YU43697B (en) 1989-10-31
HK106290A (en) 1990-12-28
GR861065B (en) 1986-09-01
CS287286A2 (en) 1989-11-14
FI84268C (fi) 1991-11-11
ZW9086A1 (en) 1986-12-03
HUT41033A (en) 1987-03-30
DK182486A (da) 1986-10-23
DK163584C (da) 1992-08-10
AU5616886A (en) 1986-11-06
IE59014B1 (en) 1993-12-15
OA08245A (fr) 1987-10-30
HU195223B (en) 1988-04-28
BE904646A (fr) 1986-10-21
NL192205B (nl) 1996-11-01
IT1228241B (it) 1991-06-05
GB8609661D0 (en) 1986-05-29
LU86402A1 (fr) 1986-11-05
CY1571A (en) 1991-12-20
NO861430L (no) 1986-10-23
ZA862985B (en) 1986-12-30
IE861048L (en) 1986-10-22
PT82436A (en) 1986-05-01
NO164659C (no) 1990-10-31
MY100694A (en) 1991-01-17
KR860008189A (ko) 1986-11-12
JPS61249989A (ja) 1986-11-07
ES8800236A1 (es) 1987-10-16
SE8601825D0 (sv) 1986-04-21
CA1273629A (fr) 1990-09-04
AU589170B2 (en) 1989-10-05
CN1015714B (zh) 1992-03-04
FI84268B (fi) 1991-07-31
SG90890G (en) 1991-01-18
FI861634A (fi) 1986-10-23
ZM4286A1 (en) 1989-03-27
NL192205C (nl) 1997-03-04
DK163584B (da) 1992-03-16
GB2173798B (en) 1988-11-30
CN86102630A (zh) 1987-02-04
CH671399A5 (fr) 1989-08-31
NO164659B (no) 1990-07-23
PT82436B (pt) 1988-11-30
ES554215A0 (es) 1987-10-16
NL8601011A (nl) 1986-11-17
AR242581A1 (es) 1993-04-30
ATA106786A (de) 1990-07-15
EG18001A (en) 1991-11-30
DD244557A5 (de) 1987-04-08
JPH0327554B2 (fr) 1991-04-16
FR2580652B1 (fr) 1989-01-06
DK182486D0 (da) 1986-04-21
GB2173798A (en) 1986-10-22
FI861634A0 (fi) 1986-04-17
SE500217C2 (sv) 1994-05-09
SU1435155A3 (ru) 1988-10-30
FR2580652A1 (fr) 1986-10-24
SE8601825L (sv) 1986-10-23
DE3613365A1 (de) 1987-01-02
DE3613365C2 (fr) 1989-06-15
IT8620162A0 (it) 1986-04-21
AT392072B (de) 1991-01-25
CS270435B2 (en) 1990-06-13
YU65986A (en) 1987-12-31

Similar Documents

Publication Publication Date Title
EP0191562A3 (en) Tetrahydrocarbazolone derivatives
EP0186187A3 (en) Cephalosporin derivatives
EP0182210A3 (en) Cephalosporin derivatives
EP0188255A3 (en) Cephem derivatives
GB8601292D0 (en) 13beta-alkylmilbemycin derivatives
GB8617292D0 (en) Poly-4-aminopyyrrole-2-carboxamido derivatives
GB2176181B (en) Aryltetralin derivatives
NZ215717A (en) Cephalosporin derivatives
GB8614176D0 (en) Piperonylcarboxamido derivatives
GB2172286B (en) Tetraprenylamine derivatives
GB2174703B (en) Pyridinylpiperazine derivatives
GB2177692B (en) Diazinylpiperidine derivatives
GB8520631D0 (en) Derivatives
GB8511892D0 (en) Fluoralkane derivatives
GB2177695B (en) Aminoalkylamide derivatives
GB8600575D0 (en) Benzonorbornene derivatives
GB2174092B (en) Eburnamenine derivatives
GB2177090B (en) 10-alpha-methoxy-6-methyl-ergoline derivatives
DE3573920D1 (en) Cephalosporin derivatives
IE850448L (en) Cephalosporin derivatives
IL78351A0 (en) Cephalosporin derivatives
IL79200A0 (en) Cephalosporin derivatives
ZA862347B (en) Cephalosporin derivatives
IE850040L (en) Cephalosporin derivatives
GB8531743D0 (en) 10beta-halo-alkynyl-estrene derivatives